Mesenchymal Stem Cells improve phenotype of induced pluripotent stem cell (iPSC)-derived cardiomyocytes in Hypoplastic Left Heart Syndrome

IF 5.3 2区 医学 Q1 PHYSIOLOGY Physiology Pub Date : 2024-05-01 DOI:10.1152/physiol.2024.39.s1.2057
Huan-Ling Liang, Melissa Anfinson, Donna K. Mahnke, Michaela Pereckas, Amy Pan, Brandon Tefft, Joy Lincoln
{"title":"Mesenchymal Stem Cells improve phenotype of induced pluripotent stem cell (iPSC)-derived cardiomyocytes in Hypoplastic Left Heart Syndrome","authors":"Huan-Ling Liang, Melissa Anfinson, Donna K. Mahnke, Michaela Pereckas, Amy Pan, Brandon Tefft, Joy Lincoln","doi":"10.1152/physiol.2024.39.s1.2057","DOIUrl":null,"url":null,"abstract":"Hypoplastic left heart syndrome (HLHS) is a clinically and anatomically severe form of congenital heart disease (CHD). We previously demonstrated that genetic variants in the alpha myosin heavy chain (MYH6) gene are significantly associated with HLHS as well as poor outcomes in patients. Additionally, induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) carrying an MYH6-R443P head domain variant demonstrated an impaired CM phenotype including dysmorphic sarcomere structure, altered contractility, and upregulated MYH7 expression. Mesenchymal stem cells (MSCs) and their secretome are currently being explored as a potential therapeutic for cardiac injury. In this study, a possible treatment strategy for iPSC-CMs with a MYH6 tail domain variant was examined through investigation of co-culturing umbilical cord tissue derived MSCs from a healthy newborn. iPSC-CMs from an unaffected family member were included as a normal control to compare cellular RNA and protein changes observed in the MYH6-E1584K line. The MYH6-E1584K variant line demonstrated significant upregulation of sarcomere, calcium channel, and inflammation/immune related gene expression in both mRNA and protein levels. Co-culturing with MSCs rescued expression of several genes and was confirmed through label free proteomic analysis. Co-culturing iPSC-CMs with MSCs also significantly improved contraction (contraction maximum displacement and velocity) in MYH6-E1584K iPSC-CMs. Finally, measurements of microRNA, cytokines, and exosomes secreted into cultured media indicated significant changes. This study suggests that MSC secreted factors improve CM expression and function and may elucidate a new mechanistic target for patients with HLHS. AHW/HHI Innovation Pilot Award. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.","PeriodicalId":49694,"journal":{"name":"Physiology","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1152/physiol.2024.39.s1.2057","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hypoplastic left heart syndrome (HLHS) is a clinically and anatomically severe form of congenital heart disease (CHD). We previously demonstrated that genetic variants in the alpha myosin heavy chain (MYH6) gene are significantly associated with HLHS as well as poor outcomes in patients. Additionally, induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) carrying an MYH6-R443P head domain variant demonstrated an impaired CM phenotype including dysmorphic sarcomere structure, altered contractility, and upregulated MYH7 expression. Mesenchymal stem cells (MSCs) and their secretome are currently being explored as a potential therapeutic for cardiac injury. In this study, a possible treatment strategy for iPSC-CMs with a MYH6 tail domain variant was examined through investigation of co-culturing umbilical cord tissue derived MSCs from a healthy newborn. iPSC-CMs from an unaffected family member were included as a normal control to compare cellular RNA and protein changes observed in the MYH6-E1584K line. The MYH6-E1584K variant line demonstrated significant upregulation of sarcomere, calcium channel, and inflammation/immune related gene expression in both mRNA and protein levels. Co-culturing with MSCs rescued expression of several genes and was confirmed through label free proteomic analysis. Co-culturing iPSC-CMs with MSCs also significantly improved contraction (contraction maximum displacement and velocity) in MYH6-E1584K iPSC-CMs. Finally, measurements of microRNA, cytokines, and exosomes secreted into cultured media indicated significant changes. This study suggests that MSC secreted factors improve CM expression and function and may elucidate a new mechanistic target for patients with HLHS. AHW/HHI Innovation Pilot Award. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
间充质干细胞改善诱导多能干细胞(iPSC)衍生的左心发育不全综合征心肌细胞的表型
左心发育不全综合征(HLHS)是一种临床和解剖学上严重的先天性心脏病(CHD)。我们以前曾证实,α肌球蛋白重链(MYH6)基因的遗传变异与HLHS以及患者的不良预后密切相关。此外,携带MYH6-R443P头部结构域变异的诱导多能干细胞衍生心肌细胞(iPSC-CMs)表现出受损的CM表型,包括肌节结构畸形、收缩力改变和MYH7表达上调。间充质干细胞(MSCs)及其分泌物目前正被探索作为治疗心脏损伤的潜在疗法。在本研究中,通过研究与来自健康新生儿的脐带组织间充质干细胞的共同培养,探讨了对具有 MYH6 尾部结构域变异的 iPSC-CMs 的可能治疗策略。MYH6-E1584K变异株的肌节、钙通道和炎症/免疫相关基因表达在mRNA和蛋白质水平上都有显著上调。与间充质干细胞共培养可挽救多个基因的表达,并通过无标记蛋白质组分析得到证实。与间充质干细胞共培养 iPSC-CMs 还能显著改善 MYH6-E1584K iPSC-CMs 的收缩能力(收缩最大位移和速度)。最后,对培养基中分泌的微RNA、细胞因子和外泌体的测量结果表明,它们都发生了显著变化。这项研究表明,间充质干细胞分泌的因子可改善CM的表达和功能,并可能为HLHS患者阐明一个新的机制靶点。AHW/HHI创新试验奖。本文是在 2024 年美国生理学峰会上发表的摘要全文,仅提供 HTML 格式。本摘要没有附加版本或附加内容。生理学未参与同行评审过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Physiology
Physiology 医学-生理学
CiteScore
14.50
自引率
0.00%
发文量
37
期刊介绍: Physiology journal features meticulously crafted review articles penned by esteemed leaders in their respective fields. These articles undergo rigorous peer review and showcase the forefront of cutting-edge advances across various domains of physiology. Our Editorial Board, comprised of distinguished leaders in the broad spectrum of physiology, convenes annually to deliberate and recommend pioneering topics for review articles, as well as select the most suitable scientists to author these articles. Join us in exploring the forefront of physiological research and innovation.
期刊最新文献
Beyond ATP: Metabolite networks as regulators of erythroid differentiation. ECM Microenvironment in Vascular Homeostasis: New Targets for Atherosclerosis. Physiology in Perspective. Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease. New Insights into IGF-1 Signaling in the Heart.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1